Icosavax: Icosavax surges 45% in pre-market trading as AstraZeneca agrees takeover
Vaccines specialist Icosavax Inc (NASDAQ: ICVX) is set to surge 45% on Tuesday after agreeing to be taken over by Anglo-Swedish pharma group AstraZeneca PLC...
Read full article »
Icosavax is a Washington-based biotechnology company that researches and develops VLP vaccines for the treatment of respiratory diseases.
Read more